Literature DB >> 26837507

Preliminary outcome of hemi-Descemet membrane endothelial keratoplasty for Fuchs endothelial dystrophy.

Nadine Gerber-Hollbach1,2, Jack Parker1,3, Lamis Baydoun1,2,4, Vasilios S Liarakos1,2, Lisanne Ham1,2,4, Isabel Dapena1,2, Gerrit Rj Melles1,2,4.   

Abstract

BACKGROUND/AIMS: To evaluate the clinical outcome of a full-diameter, untrephined, semicircular Descemet graft in a consecutive series of Descemet membrane endothelial keratoplasty (hemi-DMEK), potentially allowing the harvesting of two grafts from a single donor corneoscleral rim.
METHODS: Interventional case series of 10 eyes of 10 patients with Fuchs endothelial dystrophy. Best corrected visual acuity (BCVA), endothelial cell density (ECD) and central corneal thickness (CCT) were evaluated up to 6 months postoperatively, and intraoperative and postoperative complications were recorded.
RESULTS: Hemi-DMEK was successful in 9 out of 10 eyes; one eye showed persistent graft detachment despite rebubbling and underwent a secondary DMEK. BCVA improved in all successful hemi-DMEK eyes: at 6 months 100% of eyes (n=7) reached ≥20/40 (≥0.5), 86% (n=6) ≥20/25 (≥0.8), 29% (n=2) ≥20/20 (≥1.0) and 14% (n=1) reached 20/17 (≥1.2). Two eyes were excluded from visual analysis due to low visual potential. Preoperative donor ECD declined from 2744 (±181) cells/mm2 to 940 (±380) cells/mm2 centrally at 6 months postoperatively (n=9), with (donor and/or host) endothelial cell redistribution over bare stromal areas adjacent to the graft. Average CCT decreased from 745 (±153) µm preoperatively to 520 (±37) µm at 6 months. Four eyes required rebubbling for visually significant graft detachment. No other complications occurred throughout the study period.
CONCLUSIONS: Hemi-DMEK may give visual outcomes similar to those in conventional DMEK. If ECD decrease and graft detachment rate would prove acceptable in larger series, hemi-DMEK could have the potential to double the availability of donor tissue for endothelial keratoplasty. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/.

Entities:  

Keywords:  Cornea; Eye (Tissue) Banking; Treatment Surgery

Mesh:

Year:  2016        PMID: 26837507     DOI: 10.1136/bjophthalmol-2015-307783

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Endothelial keratoplasty: is Descemet membrane endothelial keratoplasty the way forward? Yes.

Authors:  V S Liarakos; M Tsatsos; M Satue; G R J Melles
Journal:  Eye (Lond)       Date:  2017-04-07       Impact factor: 3.775

Review 2.  Fuchs endothelial corneal dystrophy and corneal endothelial diseases: East meets West.

Authors:  Y Q Soh; Viridiana Kocaba; Mauricio Pinto; Jodhbir S Mehta
Journal:  Eye (Lond)       Date:  2019-07-02       Impact factor: 3.775

3.  Improving the success rate of human corneal endothelial cell cultures from single donor corneas with stabilization medium.

Authors:  D Spinozzi; A Miron; M Bruinsma; J T Lie; I Dapena; S Oellerich; G R J Melles
Journal:  Cell Tissue Bank       Date:  2017-10-17       Impact factor: 1.522

4.  Optimisation of Storage and Transportation Conditions of Cultured Corneal Endothelial Cells for Cell Replacement Therapy.

Authors:  Stephen Wahlig; Gary S L Peh; Khadijah Adnan; Heng-Pei Ang; Chan N Lwin; F Morales-Wong; Hon Shing Ong; Matthew Lovatt; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

Review 5.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

6.  Topographic characteristics after Descemet's membrane endothelial keratoplasty and Descemet's stripping automated endothelial keratoplasty.

Authors:  Takahiko Hayashi; Takefumi Yamaguchi; Kentaro Yuda; Naoko Kato; Yoshiyuki Satake; Jun Shimazaki
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

7.  The Rapid Transformation of Transplantation for Corneal Endothelial Diseases: An Evolution From Penetrating to Lamellar to Cellular Transplants.

Authors:  Jie Zhang; Dipika V Patel; Charles N J McGhee
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2019 Nov-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.